Picture of Newron Pharmaceuticals SpA logo

NWRN — Newron Pharmaceuticals SpA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Swiss stocks - Factors to watch on September 7

ZURICH/BERLIN, Sept 7 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
   
    HOLCIM  HOLN.S 
    France's highest appeal court set to rule on whether Lafarge
should stand trial on charges of complicity in crimes against
humanity over its operations in Syria in 2013 and 2014
    
    COMPANY STATEMENTS
    * Givaudan SA  GIVN.S : launches new protein hub at its
flagship Zurich innovation centre in Kemptthal, Switzerland
 GIVN.S 
    * Schaffner Holding AG  SAHN.S : aligns management structure
with focused strategy  SAHN.S 
    * Newron Pharmaceuticals SPA  NWRN.S : receives fourth
tranche from financing agreement with European Investment Bank
 NWRN.S     
    * Formulafirst  FFI.S  swings to H1 profit  FFI.S 
    
    ANALYSTS' VIEWS
    ROCHE HOLDING AG  ROG.S : JEFFERIES RAISES TARGET PRICE TO
CHF 415 FROM CHF 400 
    FLUGHAFEN ZUERICH AG  FHZN.S : HSBC CUTS TARGET PRICE TO CHF
160 FROM CHF 170
    
    ECONOMY
    Swiss August unemployment rate due at 0545 GMT. Seen +2.8%
(unadjusted), +3.0% (adjusted) 
    Swiss August forex reserves due around 0700 GMT


 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Newron Pharmaceuticals SpA

See all news